Parkinson Clinical Trials 2023

Browse 100 Parkinson Medical Studies Across 174 Cities

7 Phase 3 Trial · 546 Parkinson Clinics

Reviewed by Michael Gill, B. Sc.
10 Parkinson Clinical Trials Near Me
Top Hospitals for Parkinson Clinical Trials
Image of Toronto Western Hospital in Ontario.
Toronto Western Hospital
Toronto
6Active Trials
0All Time Trials for Parkinson
2018First Parkinson Trial
Image of Rush University Medical Center in Illinois.
Rush University Medical Center
Chicago
5Active Trials
0All Time Trials for Parkinson
2016First Parkinson Trial
Image of Cleveland Clinic in Ohio.
Cleveland Clinic
Cleveland
4Active Trials
0All Time Trials for Parkinson
2019First Parkinson Trial
Image of University of Pennsylvania in Pennsylvania.
University of Pennsylvania
Philadelphia
4Active Trials
0All Time Trials for Parkinson
2019First Parkinson Trial
Image of Stanford University in California.
Stanford University
Stanford
3Active Trials
0All Time Trials for Parkinson
2022First Parkinson Trial
Top Cities for Parkinson Clinical Trials
Image of New York in New York.
New York
21Active Trials
Weill Cornell Medical CollegeTop Active Site
Image of Philadelphia in Pennsylvania.
Philadelphia
18Active Trials
University of PennsylvaniaTop Active Site
Parkinson Clinical Trials by Phase of TrialParkinson Clinical Trials by Age Group
18 - 65 Parkinson Clinical Trials
1Active Parkinson Clinical Trials
Most Recent Parkinson Clinical TrialsTop Treatments for Parkinson Clinical Trials
Treatment Name
Active Parkinson Clinical Trials
All Time Trials for Parkinson
First Recorded Parkinson Trial
Tavapadon
3
3
2019
Deep Brain Stimulation
2
2
2017
UCB0599
2
2
2020
Vibrotactile Coordinated Reset (vCR)
2
2
2022
Movement task
2
2
2022

What Are Parkinson's Clinical Trials?

Parkinson's disease, commonly called Parkinson, is a degenerative brain disorder targeting the part of the brain responsible for movements. As the brain loses the nerve cells responsible for movement, the patient experiences difficulty moving and maintaining balance and uncontrolled movements such as shaking and tremors.

Parkinson's affects one to two of every thousand people. But according to experts, the percentage is higher as many patients get misdiagnosed or go undiagnosed. The disorder is caused by exposure to environmental toxins, but those who carry the genetic component are more likely to suffer from the disorder.

Parkinson's clinical trials seek to understand the causes of the disorder and develop better methods to diagnose the disorder, slow down its progression, and treat it. Parkinson's clinical trials also aim to find ways to prevent the onset in those at risk.

Why Is Parkinson Being Studied Through Clinical Trials?

Living with Parkinson's is challenging. It causes slowed movement, muscle stiffness, impaired balance, poor coordination, and tremors in hands, legs, arms, feet, head, and jaw. As a result, patients with Parkinson's experience a high risk of falls and injuries. Stiffness of muscles also leads to constipation, urinary problems, and difficulty in speaking, chewing, and swallowing.

The symptoms make everyday life challenging, impacting the patients' emotional health and leading to depression. As the disorder progresses, patients may also experience loss of cognitive functions and memory.

Parkinson's clinical trials allow health and medical experts to understand its causes, detect it earlier, and prevent or treat it effectively. The disorder is studied through clinical trials to provide better help to those at risk and those suffering from it.

What Are the Types of Treatments Available for Parkinson's?

Unfortunately, there is no definitive cure available for Parkinson's. However, therapies, surgical treatments, and medication can help treat or cope with symptoms.

Patients with Parkinson's are commonly prescribed levodopa to increase the dopamine levels in their brains. Patients are also advised to practice yoga, tai chi, and a healthy lifestyle involving exercise to improve muscle health and coordination. Speech and physical therapies have also been found as beneficial treatment options.

Patients can also opt for deep brain stimulation surgery. In this surgery, the surgeon implants an electrical device in the patient's chest connected to the implanted electrodes in the brain part affected by the disorder. The implants improve the coordination between the brain and body, preventing or improving movement-related symptoms.

What Are Some Recent Breakthrough Clinical Trials for Parkinson's?

2023: The University of Maryland School of Medicine, USA, ran a successful clinical trial testing a non-invasive ultrasound treatment. The incisionless procedure was performed on only one side of the patients' brains as they lay in an MRI scanner, fully awake. They provided feedback during the procedure, allowing the doctors to adjust the treatment as needed. The procedure resulted in an improvement of symptoms, with the patients experiencing and expressing relief.

2023: The University of Colorado, USA, ran a clinical trial focusing on a particular protein that connects Parkinson's disorder and inflammation. The clinical trial was deemed successful in providing insight into possible disease triggers. Scientists and health experts aim to utilize the new information to develop new treatment methods.

Who Some of the Key Opinion Leaders/Researchers Are in Parkinson's Clinical Trial Research?

The Parkinson's Foundation is the leading platform dedicated to conducting research and clinical trials on Parkinson's.

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 24th, 2021

Last Reviewed: August 28th, 2023

References1 Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9. doi: 10.1111/j.1532-5415.2005.53221.x. Erratum In: J Am Geriatr Soc. 2019 Sep;67(9):1991. https://pubmed.ncbi.nlm.nih.gov/158170192 Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9. Erratum in: J Am Geriatr Soc. 2019 Sep;67(9):1991. https://pubmed.ncbi.nlm.nih.gov/158170193 Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063. https://pubmed.ncbi.nlm.nih.gov/33978654 Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. https://pubmed.ncbi.nlm.nih.gov/33978655 BECK AT, WARD CH, MENDELSON M, MOCK J, ERBAUGH J. An inventory for measuring depression. Arch Gen Psychiatry. 1961 Jun;4:561-71. https://pubmed.ncbi.nlm.nih.gov/136883696 BECK AT, WARD CH, MENDELSON M, MOCK J, ERBAUGH J. An inventory for measuring depression. Arch Gen Psychiatry. 1961 Jun;4:561-71. doi: 10.1001/archpsyc.1961.01710120031004. No abstract available. https://pubmed.ncbi.nlm.nih.gov/136883697 Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N; Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15;23(15):2129-70. doi: 10.1002/mds.22340. https://pubmed.ncbi.nlm.nih.gov/190259848 HAMILTON M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-5. doi: 10.1111/j.2044-8341.1959.tb00467.x. No abstract available. https://pubmed.ncbi.nlm.nih.gov/136385089 HAMILTON M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-5. https://pubmed.ncbi.nlm.nih.gov/1363850810 Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995 Jul;167(1):99-103. doi: 10.1192/bjp.167.1.99. https://pubmed.ncbi.nlm.nih.gov/7551619